ENG
Solution & Service
Manufacturing Service
Overview

The production site is located in the National Level Industry Zone in Taizhou City, Zhejiang Province. We established a robust quality system that has passed the FDA, WHO, EDQM, ANVISA, and NMPA's on-site inspections. 3 US-DMF have been filed, 2 EU GMPs and 4 CEP were granted. Excellent EHS system to support supply sustainability. The EHS system has passed PSCI and many big pharma inspections. With the collaboration of R&D Centers and the Taizhou site, we provide integrated small molecule solutions, from GLP Tox, Clinical Phase, to commercial supply with the scale ofgram, KG to Tons.

Langhua's Strength

Langhua has a flexible, project-driven approach to customers' requests, targeting a custom-made solution fit for your purpose and requirements. With the experienced project management team, Langhua commits to delivering the project on time, on budget, and to the expected quality standard.

To meet the capacity needs of fast-growing CDMO projects, Langhua will invest 150 Million dollars to build 4 state-of-the-art multifunction workshops within the next 3 years. The new investment will increase the total reactor volume to 1500 m³.

Production Capability

We have a 1000M3 reactor volume, from 50L to 12000L various material reactors, including 200L and 1500L GMP hydrogenation reactors, can handle various reactions including low temperature (-80 ℃), high temperature (250 ℃), and high-pressure (up to 9.9 Mpa).